First Time Loading...
B

Beijing Andawell Science & Technology Co Ltd
SZSE:300719

Watchlist Manager
Beijing Andawell Science & Technology Co Ltd
SZSE:300719
Watchlist
Price: 22.29 CNY 4.99% Market Closed
Updated: May 15, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

1.6B
+9%
Assets
Growth Rates:
1 Year
+28%
3 Years
+10%
5 Years
+37%
7 Years
-
10 Years
-
504.2m
+8%
Liabilities
Growth Rates:
1 Year
+87%
3 Years
+29%
5 Years
+132%
7 Years
-
10 Years
-
1.1B
+9%
Equity
Growth Rates:
1 Year
+12%
3 Years
+3%
5 Years
+15%
7 Years
-
10 Years
-

Balance Sheet Decomposition
Beijing Andawell Science & Technology Co Ltd

1.6B
Assets
504.2m
Liabilities
1.6B
Assets
504.2m
Liabilities
Current Assets 1.4B
Cash & Short-Term Investments 297.5m
Receivables 795m
Other Current Assets 314.5m
Non-Current Assets 182.6m
PP&E 134m
Intangibles 9.5m
Other Non-Current Assets 39.2m
Current Liabilities 479.9m
Accounts Payable 174.5m
Accrued Liabilities 65.1m
Short-Term Debt 193.4m
Other Current Liabilities 47m
Non-Current Liabilities 24.3m
Long-Term Debt 14.3m
Other Non-Current Liabilities 10m

Balance Sheet
Beijing Andawell Science & Technology Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
112
122
238
265
215
305
300
249
208
297
Cash
0
0
0
0
0
0
0
249
208
294
Cash Equivalents
112
122
238
265
215
305
300
0
0
4
Short-Term Investments
0
0
0
0
0
0
0
0
0
0
Total Receivables
183
148
173
425
590
618
752
594
546
795
Accounts Receivables
152
131
145
392
497
572
624
544
496
775
Other Receivables
31
18
28
33
93
46
129
49
50
20
Inventory
75
102
109
105
159
209
232
250
283
293
Other Current Assets
5
4
5
204
65
8
11
13
12
22
Total Current Assets
374
376
524
998
1 030
1 141
1 296
1 107
1 050
1 407
PP&E Net
99
96
94
94
108
124
124
134
145
134
PP&E Gross
99
96
94
94
108
124
124
134
145
134
Accumulated Depreciation
24
31
40
48
58
68
79
97
114
132
Intangible Assets
9
9
10
12
12
12
11
11
10
9
Note Receivable
0
0
0
0
0
0
0
0
0
1
Long-Term Investments
0
2
2
2
2
2
1
0
0
0
Other Long-Term Assets
3
5
4
8
12
11
12
20
36
38
Total Assets
485
N/A
489
+1%
634
+30%
1 113
+76%
1 163
+5%
1 289
+11%
1 444
+12%
1 271
-12%
1 241
-2%
1 590
+28%
Liabilities
Accounts Payable
60
48
58
74
126
104
118
95
87
174
Accrued Liabilities
25
22
48
43
52
46
46
42
34
65
Short-Term Debt
128
125
105
4
6
137
204
85
89
193
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
6
6
6
Other Current Liabilities
33
49
22
27
30
18
20
22
30
41
Total Current Liabilities
245
244
232
148
214
305
387
249
246
480
Long-Term Debt
0
0
0
0
0
0
0
4
20
14
Deferred Income Tax
0
0
0
0
0
0
0
0
1
1
Minority Interest
23
0
0
0
0
0
0
0
0
5
Other Liabilities
1
2
3
4
4
4
5
4
4
5
Total Liabilities
269
N/A
246
-8%
235
-5%
152
-36%
217
+43%
310
+43%
392
+27%
256
-35%
270
+5%
504
+87%
Equity
Common Stock
13
13
126
168
253
254
254
254
255
255
Retained Earnings
203
229
190
279
251
273
344
303
252
366
Additional Paid In Capital
0
0
84
514
442
452
454
458
473
474
Treasury Stock
0
0
0
0
0
0
0
0
10
9
Total Equity
216
N/A
242
+12%
399
+65%
962
+141%
946
-2%
980
+4%
1 051
+7%
1 015
-3%
971
-4%
1 085
+12%
Total Liabilities & Equity
485
N/A
489
+1%
634
+30%
1 113
+76%
1 163
+5%
1 289
+11%
1 444
+12%
1 271
-12%
1 241
-2%
1 590
+28%
Shares Outstanding
Common Shares Outstanding
20
20
189
252
253
254
254
254
254
254

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.